↓ Skip to main content

A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer

Overview of attention for article published in Frontiers in oncology, April 2024
Altmetric Badge

Mentioned by

reddit
1 Redditor
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer
Published in
Frontiers in oncology, April 2024
DOI 10.3389/fonc.2024.1314301
Pubmed ID
Authors

Song Hu, Hao Ming, Qian He, Ming Ding, Hao Ding, Chong Li

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2024.
All research outputs
#23,859,973
of 26,558,362 outputs
Outputs from Frontiers in oncology
#16,892
of 23,271 outputs
Outputs of similar age
#291,296
of 352,062 outputs
Outputs of similar age from Frontiers in oncology
#394
of 484 outputs
Altmetric has tracked 26,558,362 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,271 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,062 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 484 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.